Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-22T16:11:49.908Z Has data issue: false hasContentIssue false
  • English
  • Français

Prolactin Response to Fenfluramine and Suicide Attempt Lethality in Major Depression

Published online by Cambridge University Press:  02 January 2018

Kevin M. Malone ,
Elizabeth M. Corbitt ,
Shuhua Li  and
J. John Mann
Kevin M. Malone*
Affiliation:
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, and Department of Neuroscience, New York State Psychiatric Institute
Elizabeth M. Corbitt
Affiliation:
Department of Psychiatry, University of Pittsburgh
Shuhua Li
Affiliation:
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, and Department of Neuroscience, New York State Psychiatric Institute
J. John Mann
Affiliation:
Department of Psychiatry, College of Physicians and Surgeons of Columbia University, and Department of Neuroscience, New York State Psychiatric Institute
*
Dr K. M. Malone, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, and New York State Psychiatric Institute, MHCRC for the Study of Suicidal Behaviour, Room 1501, Box 28, 722 West 168th Street, New York, NY 10032. Fax: (212) 795-8659
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

This study employed an alternative method for assessing serotonergic function to further evaluate our finding that cerebrospinal fluid (CSF) 5-hydroxyindole acetic acid (5-HIAA) in depressed suicide attempters with a lifetime history of higher lethality suicide attempts is significantly lower compared to depressed patients who have a history of low lethality suicide attempts.

Method

We used dl-fenfluramine (60 mg) as a neuroendocrine probe to examine the serotonin system in 41 in-patients with a DSM–III–R major depressive episode, divided into two groups on the basis of a lifetime history of high or low lethality suicide attempts. Fenfluramine challenge test outcome was defined as the maximum prolactin response in the five hours following fenfluramine.

Results

Patients with a history of a higher lethality suicide attempt had a significantly lower prolactin response to fenfluramine, even when controlling for cortisol, age, sex, weight, comorbid cluster B personality disorder, pharmacokinetic and menstrual cycle effects.

Conclusions

The data provide further support for the hypothesis that serotonin dysfunction is associated with more lethal suicide attempts, and suggests that higher lethality suicide attempters or failed suicides resemble completed suicides both behaviourally and biochemically.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 168 , Issue 3 , March 1996 , pp. 324 - 329
Copyright
Copyright © 1996 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
Arango, V. & Mann, J. J. (1992) Relevance of serotonergic postmortem studies to suicidal behaviour. International Review of Psychiatry, 4, 131–140.CrossRefGoogle Scholar
Beck, A. T., Weissman, A., Lester, D., et al (1974) The measurement of pessimism: The Hopelessness Scale. Journal of Consulting and Clinical Psychology, 42, 861–865.CrossRefGoogle ScholarPubMed
Beck, A. T., Beck, R. & Kovacs, M. (1975) Classification of suicidal behaviours: I. Quantifying intent and medical lethality. American Journal of Psychiatry, 132, 285–287.Google ScholarPubMed
Beck, A. T., Ward, C. H., Mendolson, M., et al (1976) An inventory for measuring depression. Archives of General Psychiatry, 33, 766–771.Google Scholar
Beck, A. T., Kovacs, M. & Weissman, A. (1979) Assessment of suicidal intention: The Scale for Suicide Ideation. Journal of Consulting and Clinical Psychology, 47, 343–352.CrossRefGoogle ScholarPubMed
Carlton, J. & Rowland, N. E. (1989) Long term actions of d-fenfluramine in two rat models of obesity. I. Sustained reductions in body weight and adiposity without depletion of brain serotonin. International Journal of Obesity, 13, 825–847.Google ScholarPubMed
Coccaro, E. F., Siever, L. J., Klar, H. M., et al (1989) Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry, 46, 587–599.CrossRefGoogle ScholarPubMed
Coccaro, E. F., Kavoussi, R. J. & Hauger, R. (1993) PRL responses to d-fenfluramine and DL-fenfluramine in man. ACNP 32nd Annual Meeting, Maui, Hawaii, p. 160.Google Scholar
Corbitt, E., Malone, K. M., Haas, G., et al (1996) Suicidal behaviour, comorbid personality disorder and major depression. Journal of Affective Disorders, in press. Google Scholar
Hamilton, M. (1960) A Rating Scale for Depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.CrossRefGoogle ScholarPubMed
Loranger, A. W., Susman, V. L., Oldham, J. M., et al (1987) The Personality Disorder Examination: a preliminary report. Journal of Personality Disorders, 1, 1–13.CrossRefGoogle Scholar
Malone, K. M. (1994) Psychobiology of suicidal behaviour in major depression. MD Thesis. National University of Ireland.Google Scholar
Mann, J. J., McBride, P. A., Malone, K. M., et al (1995) Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology, 3, 53–64.CrossRefGoogle Scholar
Mann, J. J., McBride, P. A., Brown, R. A., et al (1992) Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Archives of General Psychiatry, 49, 442–446.CrossRefGoogle ScholarPubMed
Mieczkowski, T. A., Sweeney, J. A., Haas, G. L., et al (1993) Factor composition of the suicide intent scale. Suicide and Life-Threatening Behaviour, 23, 37–45.CrossRefGoogle ScholarPubMed
Muldoon, M. F., Kaplan, J. R., Manuck, S. B., et al (1991) Effects of dietary fat on central nervous system serotonergic activity. American Psychosomatic Society, 53, 216.Google Scholar
O'Keane, V. & Dinan, T. G. (1991a) Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function. American Journal of Psychiatry, 148, 1009–1015.Google ScholarPubMed
O'Keane, V., O'Hanlon, M., Webb, M., et al (1991b) d-fenfluramine/prolactin response throughout the menstrual cycle: Evidence for an oestrogen-induced alteration. Clinical Endocrinology, 34, 289–292.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.